Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	21118
Country	Lebanon

Received	2015-06-30 15:31
Peer-Review Started	2015-07-02 09:01
To Make the First Decision	2015-09-16 09:12
Return for Revision	2015-09-22 16:44
Revised	2015-11-09 19:15
Second Decision	2015-12-10 17:59
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-12-21 11:10
Articles in Press	2015-12-21 11:10
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-02-26 09:35
Publish the Manuscript Online	2016-03-07 11:32

ISSN	1948-5204 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/ licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Is metastatic pancreatic cancer an untargetablemalignancy?
Manuscript Source	Invited Manuscript
All Author List	Hampig Raphael Kourie, Joseph Gharios, Fadi Elkarak, Joelle Antoun and Marwan Ghosn
Funding Agency and Grant Number
Corresponding Author	Marwan Ghosn, MD, Department of Oncology, Faculty of Medicine, Saint Joseph University, Monot St, PO Box 166830, Beirut, Lebanon. marwanghonmd@yahoo.com
Key Words	Pancreatic cancer; Tumor suppressor genes; Targeted therapies; Immunotherapy; Epigenetics
Core Tip	This paper will report on the most recent updates in the treatment of metastatic pancreatic cancer (MPC). We present the major causes rendering MPC an untargetable malignancy and we focus on the new therapeutic modalities based on targeted therapies in MPC.
Publish Date	2016-03-07 11:32
Citation	Kourie HR, Gharios J, Elkarak F, Antoun J, Ghosn M. Is metastatic pancreatic cancer an untargetable malignancy? World J Gastrointest Oncol 2016; 8(3): 297-304
URL	http://www.wjgnet. com/1948-5204/full/v8/i3/297.htm
DOI	http://dx.doi.org/10.4251/wjgo.v8.i3.297

Full Article (PDF)	WJGO-8-297.pdf
Full Article (Word)	WJGO-8-297.doc
Manuscript File	21118-Review.docx
Answering Reviewers	21118-Answering reviewers.pdf
Audio Core Tip	21118-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	21118-Conflict-of-interest statement.pdf
Copyright License Agreement	21118-Copyright assignment.pdf
Peer-review Report	21118-Peer-review(s).pdf
Scientific Misconduct Check	21118-Scientific misconduct check.pdf
Scientific Editor Work List	21118-Scientific editor work list.pdf